Compound information
- Natural Products
- ZC3565613
- Molecular Formula
- C28H31FN6O2
- Molecular Weight
- 502.249252452 g/mol
- Structure
-
- IUPAC Name
- N-[2-[2-(dimethylamino)ethyl-methyl-amino]-5-[[5-(4-fluorophenyl)-1H-indazol-3-yl]amino]-4-methoxy-phenyl]prop-2-enamide
- InChI
- InChI=1S/C28H31FN6O2/c1-6-27(36)30-23-16-24(26(37-5)17-25(23)35(4)14-13-34(2)3)31-28-21-15-19(9-12-22(21)32-33-28)18-7-10-20(29)11-8-18/h6-12,15-17H,1,13-14H2,2-5H3,(H,30,36)(H2,31,32,33)
- InChI Key
- IOFPXKOUVACVHI-UHFFFAOYSA-N
- SMILES
- C=CC(=O)Nc1cc(Nc2n[nH]c3ccc(-c4ccc(F)cc4)cc23)c(OC)cc1N(C)CCN(C)C
- Source
- ZINC001772623960
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 37 | Ring Count | 4 |
Heteroatom Count | 9 | Rotatable Bond Count | 10 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 3 |
Topological Polar Surface Area | 85.52 Å2 | LogP | 5.158 |
LogS | -4.548 | LogD | 4.357 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.84 | Pgp substrate | 0.979 |
HIA | 0.959 | F20 % | 0.994 |
F30 % | 0.923 | Caco-2 | -4.937 |
MDCK | -5.17 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.086 | PPB | 99.059 |
VD | 1.239 | Fu | 1.695 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.46 | CYP1A2 substrate | 0.78 |
CYP2A6 substrate | 0.32 | CYP2B6 substrate | 0.667 |
CYP2C19 inhibitor | 0.144 | CYP2C19 substrate | 0.92 |
CYP2C8 substrate | 0.933 | CYP2C9 inhibitor | 0.121 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.123 |
CYP2D6 substrate | 0.996 | CYP2E1 substrate | 0.414 |
CYP3A4 inhibitor | 0.558 | CYP3A4 substrate | 0.994 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.103 | CL | 5.128 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.786 | Hepatotoxicity | 0.809 |
Mutagenicity | 0.031 | Rat Oral Acute Toxicity | 0.148 |
FDAMDD | 0.804 | Skin Sensitization | 0.911 |
Carcinogenicity | 0.096 | Eye Corrosion | 0.003 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.892 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 1.18 | IGC50 | 3.881 |
LC50FM | -3.058 | LC50DM | 0.056 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.374 | NR-AR-LBD | 0.868 |
NR-AhR | 0.951 | NR-Aromatase | 0.55 |
NR-ER | 0.567 | NR-ER-LBD | 0.594 |
NR-PPAR-gamma | 0.956 | SR-ARE | 0.941 |
SR-ATAD5 | 0.886 | SR-HSE | 0.742 |
SR-MMP | 0.928 | SR-p53 | 0.924 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.